What is Haisco Pharmaceutical Group Co Operating Cash Flow per Share?
Haisco Pharmaceutical Group Co's operating cash flow per share for the
three
months ended in Mar. 2024 was ¥0.05.
Haisco Pharmaceutical Group Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.42.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Haisco Pharmaceutical Group Co was 71.60% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 29.10% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -21.20% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -13.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Haisco Pharmaceutical Group Co's Operating Cash Flow per Share or its related term are showing as below:
SZSE:002653'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -57.8 Med: 1.8 Max: 37.3
Current: 29.1
During the past 13 years, Haisco Pharmaceutical Group Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 37.30% per year. The lowest was -57.80% per year. And the median was 1.80% per year.
SZSE:002653's 3-Year OCF Growth Rate is ranked better than 78.79% of 1235
companies
in the Biotechnology industry
Industry Median: 3.3
vs SZSE:002653: 29.10
Haisco Pharmaceutical Group Co Operating Cash Flow per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Haisco Pharmaceutical Group Co Operating Cash Flow per Share Chart
Competitive Comparison of Haisco Pharmaceutical Group Co's Operating Cash Flow per Share
For the Biotechnology subindustry, Haisco Pharmaceutical Group Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haisco Pharmaceutical Group Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Haisco Pharmaceutical Group Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Haisco Pharmaceutical Group Co's Price-to-Operating-Cash-Flow falls into.
Haisco Pharmaceutical Group Co Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Haisco Pharmaceutical Group Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.42
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haisco Pharmaceutical Group Co Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Haisco Pharmaceutical Group Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Haisco Pharmaceutical Group Co (SZSE:002653) Business Description
Haisco Pharmaceutical Group Co Ltd is a pharmaceutical company based in China. It is mainly engaged in the research, development, manufacture, and sale of drugs for liver disease. Its product portfolio includes parenteral nutrition drugs, antibiotics, anesthetic agents, digestive system drugs and tumour adjuvant drug series. The company's products are being used in first rank hospitals in China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:002653 has been successfully added to your 